Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1.076,13
-15,38
-1,41%
—1.091,511.090,401.090,401.073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1.248,82
+10,84
+0,88%
—1.237,981.237,831.252,411.225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1.724,36
-20,35
-1,17%
—1.744,711.740,951.747,291.721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3.263,41
+2,72
+0,08%
—3.260,693.273,363.287,813.240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1.462,56
-4,24
-0,29%
—1.466,801.464,701.467,191.458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2.380,40
-17,10
-0,71%
—2.397,502.395,032.412,012.370,64——
NVS:NYSE
Novartis AG
US$144,62
-1,33%
(-1,95) 1D
US$144,62
0,00% (0,00)
After hours
Closed: 4 ພ.ພ., 16 ໂມງ 0 ນາທີ 07 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVS...
Open
US$145,55
High
US$145,82
Low
US$144,45
Mkt. cap
໒໙໑,໖໔ ຕື້
Avg. vol.
໑,໕໓ ລ້ານ
Volume
໑,໗໒ ລ້ານ
Dividend
໓,໒໘%
Quarterly dividend
US$1,19
Ex dividend date
10 ມ.ນ. 2026
P/E ratio
໒໐,໗໓
52-wk high
US$170,46
52-wk low
US$104,93
EPS
US$6,98
Beta
໐,໔໕
Shares outstanding
໒,໐໓ ຕື້
No. of employees
໗໕ ພັນ
News stories
From sources across the web
Wake County Government (.gov)
Wake County Government (.gov)
·
15 ຊົ່ວໂມງກ່ອນ
Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville
marketscreener.com
marketscreener.com
·
22 ຊົ່ວໂມງກ່ອນ
Swiss stocks - Factors to watch on May 4
The Center Square
The Center Square
·
3 ມື້ກ່ອນ
Swiss drugmaker spending portion of $23B investment in Morrisville
CNBC
CNBC
·
6 ມື້ກ່ອນ
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75,3 ພັນ
Founded29 ກ.ພ. 1996
Headquartersບາເຊວ, Basel City, ສະວິດເຊີແລນ
SectorPharmaceutical industry
Websitenovartis.com
Last report
28 ມ.ສ. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
໑,໙໙/ (໒,໐໘ est.)USD
-4,54%miss
Revenue / Estimate
໑໓,໕໒ ຕື້/ (໑໓,໔໘ ຕື້ est.)USD
+0,33%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
14,84 ຕື້
14,36 ຕື້
13,86 ຕື້
13,52 ຕື້
Cost of goods sold
3,32 ຕື້
3,54 ຕື້
3,54 ຕື້
3,44 ຕື້
Cost of revenue
3,32 ຕື້
3,54 ຕື້
3,54 ຕື້
3,44 ຕື້
Research and development expenses
2,62 ຕື້
2,86 ຕື້
2,84 ຕື້
2,78 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,44 ຕື້
3,30 ຕື້
3,44 ຕື້
3,14 ຕື້
Operating expense
6,05 ຕື້
6,24 ຕື້
6,46 ຕື້
5,96 ຕື້
Total operating expenses
9,37 ຕື້
9,77 ຕື້
10,00 ຕື້
9,40 ຕື້
Operating income
5,46 ຕື້
4,58 ຕື້
3,86 ຕື້
4,12 ຕື້
Other non operating income
-13,00 ລ້ານ
-7,00 ລ້ານ
-130,00 ລ້ານ
4,00 ລ້ານ
EBT including unusual items
4,53 ຕື້
4,20 ຕື້
3,22 ຕື້
3,84 ຕື້
EBT excluding unusual items
5,16 ຕື້
4,29 ຕື້
3,49 ຕື້
3,78 ຕື້
Income tax expense
507,00 ລ້ານ
266,00 ລ້ານ
814,00 ລ້ານ
683,00 ລ້ານ
Effective tax rate
11,19%
6,34%
25,30%
17,79%
Other operating expenses
-4,00 ລ້ານ
70,00 ລ້ານ
190,00 ລ້ານ
42,00 ລ້ານ
Net income
4,04 ຕື້
3,93 ຕື້
2,41 ຕື້
3,16 ຕື້
Net profit margin
27,24%
27,36%
17,38%
23,34%
Earnings per share
2,42
2,25
2,03
1,99
Interest and investment income
-
-
373,00 ລ້ານ
-
Interest expense
-289,00 ລ້ານ
-281,00 ລ້ານ
-304,00 ລ້ານ
-343,00 ລ້ານ
Net interest expenses
-289,00 ລ້ານ
-281,00 ລ້ານ
69,00 ລ້ານ
-343,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
6,56 ຕື້
5,78 ຕື້
4,96 ຕື້
5,24 ຕື້
Gain or loss from assets sale
-67,00 ລ້ານ
81,00 ລ້ານ
80,00 ລ້ານ
-159,00 ລ້ານ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer